Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.
NCT04219241
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Huntington Disease
Interventions
BIOLOGICAL:
Cellavita-HD
Sponsor
Azidus Brasil
Collaborators
[object Object]